@Liver_Screen H2020 shifts the focus from Liver Disease to Liver Health.
Global experts use Delphi Methodology to define LIVERHEALTH Consensus Criteria — driving proactive care & informed decisions.
#HealthcareInnovation @
🚨 Join us at EASL Track Hub 8!
📍 The @Liver_Screen Journey
🩺 Developing Europe���s largest screening program for Undiagnosed Liver Fibrosis
🗓️ Thurs, 8 May 2025
🕓 16:15–16:45 CET
🎙️ Dr. Isabel Graupera & Dr. Adrià Juanola
#EASL2025 @EASLnews #Hepathology
We are still over the moon about the inclusion of 3⃣0⃣,0⃣0⃣0⃣ individuals from across different European countries!
#LiverTwitter, give us some ideas on how to celebrate this monumental, unique, outstanding, fantastic and enormous achievement.
@ebtapper, what do you suggest?
🎉Time to celebrate! 3⃣0⃣,0⃣0⃣0⃣ individuals from across different European countries have been included in the @LiverScreen project.
A HUGE thank you goes to all participating subjects, study physicians and nurses, coordinators and administrators from the Consortium.
Today, Katrine Tholstrup Bech from @FLASH_OUH in Odense, Denmark will present the @Liver_Screen poster:
Longtudinal changes in liver stiffness measurements in a population-based screening cohort of 5,517 participants
👩💼Poster ID TOP-241-YI
Don't miss the @Liver_Screen Networking Session on the 1st day of #EASLCongress2024
Wednesday, 5 June, 16:15 – 16:45, General Hepatology Track Hub
🚀The LIVERRISK SCORE: What is it and how to use it?
IF YOU DON’T TAKE CARE OF YOUR LIVER, IT DOESN’T TAKE CARE OF YOU!
FAST FACTS: Shared by #WorldLiverDay at @WorldLiverDay.
* 2 million lives are lost each year to liver disease.
* 1.5 billion suffer from chronic liver disease.
* 90% of cases are preventable.
OVER 100 DISEASES CAN AFFECT YOUR LIVER
* They can affect ANYONE regardless of age, sex, ethnicity, or socioeconomic background.
* The most common cause of chronic liver disease is steatotic liver disease (previously known as non-alcoholic fatty liver disease), accounting for 59% of cases.
For Fatty Liver Disease, now more commonly known as Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), a roadmap of actions and priorities has been published and will help address this epidemic.
1) Research priorities in SLD (JHEP, 2023): https://t.co/xpjVAsNI27
2) Action priorities in SLD (Hepatology, 2024): https://t.co/9MYVjtrJ0j
@EASLnews@AASLDtweets @CanNASHNetwork @CASLupdates@GlobalLiver@surfing_MASH@ISGLOBALorg@EuropeLiver
LIVERSCREEN contributes to the goals of the #WorldLiverDay by performing a screening for liver fibrosis in the population.
@Worldliverday
https://t.co/FnvQVPhmUX
https://t.co/PjR3fvQSv1
www.worldliverday
On World Liver Day, let's remember the importance of early detection. Regular screenings can help catch liver diseases in their early stages when treatment is most effective. #WorldLiverDay@Worldliverday
https://t.co/FnvQVPhmUX
https://t.co/PjR3fvQSv1
www.worldliverday
@idibaps@igraupe@Liver_Screen@LiverAim@NatRevGastroHep 📚 Researchers from Hospital #CLÍNIC-@idibaps publish an article proposing possible population screening strategies for liver fibrosis.
They have extracted lessons learned in cancer screening programmes to reflect on possible innovative initiatives.
👉 https://t.co/6FSnjsJ54h
Why does obesity increase all-type cancer ? Does weight loss decrease cancer risk ?
This huge meta-analysis including 24M people reviews the mechanisms and shows that a weight loss of >5 kg reduces overall cancer risk.
https://t.co/atFs0zv8VP #livertwitter #MedX